NeuroSigma
PrivateLast Round
Corporate Funding
Dec 15, 2025
Total Funding Raised
$9.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeuroSigma is a bioelectronic medical device company that develops and commercializes non-invasive trigeminal nerve stimulation (TNS) technologies for treating disorders such as pediatric ADHD, epilepsy, and depression.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroSigma Comparables
Compare NeuroSigma with similar companies based on industry and business-model similarity.
NeuroSigma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 15, 2025 | ||||
| Debt Conversion | Dec 8, 2021 | ||||
| Corporate Funding | Dec 8, 2021 | ||||
| Corporate Funding | Sep 21, 2020 | ||||
| Grant | Feb 4, 2013 |
NeuroSigma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| Checkmate Capital | Corporate Funding |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors grew 115% MoM, reaching 4K.
- Dec 15, 2025
$1M raised in corporate funding.
Recent news
Latest coverage and updates
- launchesJul 21, 2026
NeuroSigma, Inc. launched eTNS System on Jul 21st '26.
NeuroSigma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NeuroSigma's valuation, stock price, and market status.
Is NeuroSigma a public or private company?
NeuroSigma is a private company.
What is the current stock price of NeuroSigma?
NeuroSigma is a private company with no public stock price. No recent secondary market data is available.
How much is NeuroSigma worth (valuation)?
Valuation information for NeuroSigma is not publicly available.
Can I buy NeuroSigma stock?
NeuroSigma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NeuroSigma's last funding round?
NeuroSigma's most recent funding round was Corporate Funding on December 15, 2025.
Who are the main investors in NeuroSigma?
Key investors in NeuroSigma include KT Corporation, Checkmate Capital, National Institute of Neurological Disorders and Stroke.
Will NeuroSigma IPO soon?
No public IPO plans have been announced for NeuroSigma.
How can I track NeuroSigma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroSigma's secondary market activity and sign up for updates.